Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-258974
Filing Date
2024-11-14
Accepted
2024-11-14 19:21:59
Documents
1
Group Members
BIOTECH GROWTH N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d897811dsc13ga.htm SC 13G/A 48795
  Complete submission text file 0001193125-24-258974.txt   50460
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Subject) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91583 | Film No.: 241465194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)